Few terms have moved from the biochemistry lecture theatre into mainstream health conversation as quickly as “peptide”. In regenerative and functional medicine, therapeutic peptides have become a subject of serious clinical interest — not as a fashionable supplement, but as precise signalling molecules that interact with specific biological pathways. This article explains, in accurate terms, what peptides are, how they work, the principal classes used clinically, and where they sit within a root-cause, systems-based model of care.
What a peptide is, precisely
A peptide is a short chain of amino acids linked by peptide bonds — typically fewer than around fifty residues, which distinguishes peptides from the larger, more complex proteins. The body synthesises thousands of endogenous peptides that function as messengers within the endocrine, immune and nervous systems. Familiar examples include insulin and the incretin hormone GLP-1 — both peptides, and both central to metabolic regulation.
What makes peptides therapeutically interesting is their specificity. Many act as receptor agonists: they bind a particular cell-surface receptor and initiate a defined downstream cascade — up-regulating tissue repair, modulating inflammatory signalling, or prompting the release of a hormone. Because a given peptide engages a narrow set of targets, it can, in principle, influence one pathway with less of the broad, off-target activity associated with some small-molecule drugs. Most therapeutic peptides also have a relatively short half-life, which is one reason dosing and delivery are handled carefully.
How functional medicine approaches peptides
In a functional-medicine framework, a peptide is never a stand-alone “fix”. It is one instrument within a plan that begins with identifying the root cause of dysfunction — informed by history, examination and appropriate laboratory biomarkers across metabolic, hormonal, nutritional and inflammatory domains. Lifestyle fundamentals come first; peptides, where indicated, are an adjunct that amplifies a properly built foundation rather than a substitute for it. (Our companion article on the Swiss habits for healthy ageing sets out those fundamentals in detail.)
The principal classes of therapeutic peptide
The peptides encountered in clinical practice can be grouped by the pathways they engage. The descriptions below reflect areas of ongoing research and are provided for education, not as medical claims.
- Tissue repair & regeneration. BPC-157 (a body-protection compound) and TB-500 (a fragment related to thymosin beta-4) are studied for their roles in angiogenesis, cellular migration and the healing of muscle, tendon and gut tissue. The copper peptide GHK-Cu is investigated for collagen synthesis, skin remodelling and wound repair.
- Metabolism, growth hormone & body composition. Growth-hormone secretagogues such as CJC-1295 with Ipamorelin stimulate the body’s own pulsatile growth-hormone release, while Tesamorelin has been studied for visceral fat reduction and AOD-9604 for fat metabolism. The widely known GLP-1 class illustrates how powerfully metabolic peptides can influence insulin sensitivity and appetite regulation.
- Longevity & cellular health. Epithalon is researched for its influence on the telomerase pathway and circadian regulation, and MOTS-c — a mitochondrial-derived peptide — for mitochondrial function and metabolic signalling, both of interest in the biology of healthy ageing.
- Cognition & mood. The neuropeptides Semax and Selank are studied for effects on focus, neuroprotection and anxiolysis, with proposed mechanisms involving BDNF and neurotransmitter modulation.
- Immune modulation. Thymosin alpha-1 and the small peptide KPV are investigated for their immunoregulatory and anti-inflammatory properties.
The full range we work with is set out on our Peptides & Services page.
Delivery, quality and regulation
Peptides are prescription medicines, and their clinical value depends entirely on quality and correct handling. At Swiss Medica, peptides are compounded by a SAHPRA-licensed compounding pharmacy, using ingredients that are assayed and tested throughout production, and delivered by temperature-controlled cold chain to preserve stability in transit. This regulatory oversight is a core reason South Africa is a credible base for legitimate peptide therapy — and a key point of difference from the unregulated “research chemical” market.
The objective is never “a peptide for everything” — it is the right molecule, for the right person, at the right time, within a considered clinical plan.
The clinical pathway at Swiss Medica
Every plan begins with an initial consultation (R450), in which we discuss your concerns and goals, recommend appropriate blood tests and functional diagnostics, and only then determine whether a specific peptide protocol is warranted. Prescribing is individualised, monitored, and integrated with nutrition, movement and, where relevant, hormonal optimisation.
Is peptide therapy right for me?
That is precisely the question a consultation is designed to answer. Peptides can be a valuable component of a plan for the right person and clinical context — and entirely unnecessary for someone else. The only responsible way to decide is a proper clinical assessment. If you would like to explore whether peptide therapy fits your goals, book a consultation with our team.
The peptide descriptions in this article reflect areas of ongoing research and are provided for general education only; they are not medical claims or guarantees of results. Peptides are prescription items dispensed after consultation. Always consult a qualified healthcare provider before starting any new therapy.